查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566943

脊椎骨水泥市場：按類型、應用和最終用戶分類：2024-2033 年全球機會分析和產業預測

Bone Cement for Spine Market By Type (Low Viscosity, Medium Viscosity, High Viscosity) , By Application (Vertebroplasty, Kyphoplasty) By End User (Hospitals, Specialty Surgical Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

脊椎骨水泥市場

2023年脊椎骨水泥市場價值為1.012億美元，預計2024年至2033年複合年成長率為5.3%，2033年達到1.686億美元。

用作脊椎骨水泥的化學物質是聚甲基丙烯酸甲酯。這種水泥特別用於脊椎手術，例如骨成形術和椎體成形術。這種水泥用於支撐脆弱、骨折的骨骼，提供力量並緩解疼痛。骨水泥的主要特性是它能夠快速硬化，為脊椎提供直接的結構支撐和穩定性。

全球脊椎手術數量的增加是脊椎骨水泥市場的主要促進因素。此外，骨脆性高的老年人口的迅速增加正在推動脊椎骨水泥的需求。最近，有一種趨勢是利用積層製造在支架和骨植入的設計中使用骨水泥。這使我們能夠根據患者的具體要求製造客製化的脊椎移植。此外，使用骨水泥作為局部藥物輸送的載體已獲得醫療保健產業的大力支持。

然而，脊柱骨水泥在體內容易發生碎裂和異物反應，導致假體關節鬆動、假體周圍骨溶解等危險狀況。這些反應正在阻礙市場的開拓。相反，脊椎手術數量的不斷激增預計將為市場開拓提供利潤豐厚的機會。根據世界衛生組織（WHO）統計，2021年全球約有1,540萬人將因交通事故、跌倒、暴力等多種原因遭受脊髓損傷。此外，根據全球資料和商業情報平台 Statista 的數據，到 2023年終，美國將有約 305,000 人遭受脊髓損傷。這些引人注目的數字表明脊柱骨水泥市場的未來充滿希望。

按部門審查

脊椎骨水泥市場按類型、應用、最終用戶和地區細分。依類型可分為低黏度、中黏度、高黏度。依應用範圍可分為椎體成形術和椎體成形術。依最終用戶分類，可分為醫院和專科手術中心。從區域來看，我們對北美、歐洲、亞太地區和拉丁美洲地區進行了分析。

主要發現

從類型來看，中黏度細分市場將在 2023 年佔據較高的市場佔有率。

從應用來看，枕葉成形術領域在 2023 年獲得了較高的市場佔有率。

按最終用戶分類，醫院細分市場在 2023 年將佔據較高市場佔有率。

按地區分類，北美地區 2023 年收益最高。

該報告可以客製化。

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 公司簡介的擴充列表
  • 歷史市場資料
  • 主要參與者的詳細資料（Excel格式，包括位置、聯絡資訊、供應商/供應商網路等）

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 主要投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章脊椎骨水泥市場：依類型

  • 市場概況
  • 低黏度
  • 中等黏度
  • 高黏度

第5章脊椎骨水泥市場：依應用分類

  • 市場概況
  • 椎體成形術
  • 椎體成形術

第6章脊椎骨水泥市場：依最終用戶分類

  • 市場概況
  • 醫院
  • 專科手術中心

第7章脊椎骨水泥市場：依地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國脊椎骨水泥市場
    • 加拿大脊椎骨水泥市場
    • 墨西哥脊椎骨水泥市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 德國脊椎骨水泥市場
    • 法國脊椎骨水泥市場
    • 英國脊椎骨水泥市場
    • 義大利脊椎骨水泥市場
    • 西班牙脊椎骨水泥市場
    • 其他歐洲國家脊椎骨水泥市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 日本脊椎骨水泥市場
    • 中國脊椎骨水泥市場
    • 澳洲脊椎骨水泥市場
    • 印度脊椎骨水泥市場
    • 韓國脊椎骨水泥市場
    • 其他亞太地區脊椎骨水泥市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西脊椎骨水泥市場
    • 沙烏地阿拉伯脊椎骨水泥市場
    • 南非脊椎骨水泥市場
    • 其他拉丁美洲/中東/非洲脊椎骨水泥市場

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第9章 公司簡介

  • Cardinal Health
  • Meta Biomed Co., Ltd
  • Heraeus Medical GmbH
  • Shanghai Rebone, Tecres SPA
  • OSARTIS GmbH
  • Stryker Corporation
  • Johnson And Johnson
  • Heraeus Medical
  • Smith And Nephew Plc
  • Medtronic
簡介目錄
Product Code: A323979

Bone Cement for Spine Market

The bone cement for spine market was valued at $101.2 million in 2023 and is projected to reach $168.6 million by 2033, growing at a CAGR of 5.3% from 2024 to 2033.

The chemical used as a bone cement for spine is polymethyl methacrylate. The cement is specifically used for spinal surgeries such as kyphoplasty and vertebroplasty. This cement is administered to provide support to weakened broken bones, provide them with strength, and aid in relieving pain. A major attribute of the bone cement is its ability to solidify quickly, providing instant structural support and stability to the spine.

Increase in the prevalence of spinal surgeries across the globe is a key driver of the bone cement for spine market. In addition, the exponentially growing elderly population with high bone fragility is boosting the demand for bone cement for spine. In recent times, the trend of using bone cement as a material for the designing of scaffolds and bone implants through additive manufacturing is acquiring noteworthy traction. This enables the creation of tailored spine implants, according to the specific requirement of patients. Furthermore, the use of bone cement as a carrier for localized drug delivery is gaining significant traction in the healthcare industry.

However, bone cement for spine remains highly susceptible to fragmentation & foreign substance reaction inside the body, which leads to threatening conditions such as prosthetic loosening and periprosthetic osteolysis. These reactions hamper the development of the market. On the contrary, a constant surge in the number of spinal surgeries is projected to present lucrative opportunities for the market development. According to the statistics of the World Health Organization, approximately 15.4 million individuals were suffering from spinal cord injuries in 2021 globally owing to several reasons such as road accidents, falls, or violence. Moreover, Statista-a global data and business intelligence platform-states that around 305,000 individuals in the U.S. had a spinal cord injury by the end of 2023. These eminent figures indicate a promising future for the bone cement for spine market.

Segment Review

The bone cement for spine market is segmented into type, application, end user, and region. On the basis of type, the market is divided into low viscosity, medium viscosity, and high viscosity. As per application, it is bifurcated into vertebroplasty and kyphoplasty. Depending on end user, it is classified into hospitals and specialty surgical centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the medium viscosity segment held a high share of the market in 2023.

As per application, the kyphoplasty segment acquired a high stake in the market in 2023.

Depending on end user, the hospitals segment was the highest shareholder of the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The key players operating in the global bone cement for spine market include Cardinal Health, Meta Biomed Co., Ltd, Heraeus Medical GmbH, Shanghai Rebone, Tecres S.P.A, OSARTIS GmbH, Stryker Corporation, Johnson & Johnson, Heraeus Medical, Smith & Nephew plc, and Medtronic. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Type

  • Low Viscosity
  • Medium Viscosity
  • High Viscosity

By Application

  • Vertebroplasty
  • Kyphoplasty

By End User

  • Hospitals
  • Specialty Surgical Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Cardinal Health
    • Meta Biomed Co., Ltd
    • Heraeus Medical GmbH
    • Shanghai Rebone, Tecres S.P.A
    • OSARTIS GmbH
    • Stryker Corporation
    • Johnson & Johnson
    • Heraeus Medical
    • Smith & Nephew plc
    • Medtronic

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: BONE CEMENT FOR SPINE MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Low Viscosity
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Medium Viscosity
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. High Viscosity
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: BONE CEMENT FOR SPINE MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Vertebroplasty
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Kyphoplasty
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: BONE CEMENT FOR SPINE MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Specialty Surgical Centers
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country

CHAPTER 7: BONE CEMENT FOR SPINE MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Bone Cement for Spine Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Bone Cement for Spine Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Bone Cement for Spine Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Bone Cement for Spine Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Bone Cement for Spine Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Bone Cement for Spine Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Bone Cement for Spine Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Bone Cement for Spine Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Bone Cement for Spine Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Bone Cement for Spine Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Bone Cement for Spine Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. Australia Bone Cement for Spine Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. India Bone Cement for Spine Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Bone Cement for Spine Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Bone Cement for Spine Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Bone Cement for Spine Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Bone Cement for Spine Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Bone Cement for Spine Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Bone Cement for Spine Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Cardinal Health
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Meta Biomed Co., Ltd
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Heraeus Medical GmbH
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Shanghai Rebone, Tecres S.P.A
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. OSARTIS GmbH
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Stryker Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Johnson And Johnson
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Heraeus Medical
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Smith And Nephew Plc
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Medtronic
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments